Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

ClinicalTrials.gov ID: NCT00068445

Public ClinicalTrials.gov record NCT00068445. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 11:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Efficacy of Lamotrigine in the Management of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double Blind, Placebo-Controlled Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Lamotrigine may be effective in reducing pain, numbness, tingling, and other symptoms of peripheral neuropathy. It is not yet known whether lamotrigine is effective in treating peripheral neuropathy caused by chemotherapy. PURPOSE: This randomized phase III trial is studying how well lamotrigine works in reducing pain, numbness, tingling, and other symptoms of peripheral neuropathy caused by chemotherapy in patients with cancer.

Study identification

NCT ID
NCT00068445
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
131 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2004 (Type not available)
Primary completion
May 2006 (Actual)
Completion
Nov 2013 (Actual)
Last update posted
May 4, 2018

2004 – 2013

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
Mayo Clinic Scottsdale Scottsdale Arizona 85259 —
Mayo Clinic - Jacksonville Jacksonville Florida 32224 —
CCOP - Atlanta Regional Atlanta Georgia 30342-1701 —
MBCCOP - Hawaii Honolulu Hawaii 96813 —
CCOP - Illinois Oncology Research Association Peoria Illinois 61615-7828 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206 —
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1854 —
Siouxland Hematology-Oncology Associates at June E. Nylen Cancer Center Sioux City Iowa 51101-1733 —
CCOP - Wichita Wichita Kansas 67214-3882 —
CCOP - Michigan Cancer Research Consortium Ann Arbor Michigan 48106 —
CCOP - Duluth Duluth Minnesota 55805 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
Coborn Cancer Center Saint Cloud Minnesota 56303 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68106 —
Cancer Care Center at Medcenter One Hospital Bismarck North Dakota 58501-5505 —
CCOP - Dayton Dayton Ohio 45429 —
CCOP - Toledo Community Hospital Toledo Ohio 43623-3456 —
CCOP - Upstate Carolina Spartanburg South Carolina 29303 —
Rapid City Regional Hospital Rapid City South Dakota 57709 —
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57104 —
CCOP - St. Vincent Hospital Cancer Center, Green Bay Green Bay Wisconsin 54301 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00068445, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2018 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00068445 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →